290 related articles for article (PubMed ID: 31864373)
1. HTLV-1 CTCF-binding site is dispensable for in vitro immortalization and persistent infection in vivo.
Martinez MP; Cheng X; Joseph A; Al-Saleem J; Panfil AR; Palettas M; Dirksen WP; Ratner L; Green PL
Retrovirology; 2019 Dec; 16(1):44. PubMed ID: 31864373
[TBL] [Abstract][Full Text] [Related]
2. The retrovirus HTLV-1 inserts an ectopic CTCF-binding site into the human genome.
Satou Y; Miyazato P; Ishihara K; Yaguchi H; Melamed A; Miura M; Fukuda A; Nosaka K; Watanabe T; Rowan AG; Nakao M; Bangham CR
Proc Natl Acad Sci U S A; 2016 Mar; 113(11):3054-9. PubMed ID: 26929370
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of HTLV-1 HBZ and proviral load, together with host IFN λ3, in pathogenesis of HAM/TSP.
Mozhgani SH; Jaberi N; Rezaee SA; Bustani R; Jazayeri SM; Akbarin MM; Milani S; Tarokhian H; Norouzi M
J Med Virol; 2017 Jun; 89(6):1102-1107. PubMed ID: 27787900
[TBL] [Abstract][Full Text] [Related]
4. HTLV-1 intragenic viral enhancer influences immortalization phenotype
Maksimova V; Smith S; Seth J; Phelps C; Niewiesk S; Satou Y; Green PL; Panfil AR
Front Immunol; 2022; 13():954077. PubMed ID: 35958554
[TBL] [Abstract][Full Text] [Related]
5. EOS, an Ikaros family zinc finger transcription factor, interacts with the HTLV-1 oncoprotein Tax and is downregulated in peripheral blood mononuclear cells of HTLV-1-infected individuals, irrespective of clinical statuses.
Naito T; Ushirogawa H; Fukushima T; Tanaka Y; Saito M
Virol J; 2019 Dec; 16(1):160. PubMed ID: 31856855
[TBL] [Abstract][Full Text] [Related]
6. Epigenomic regulation of human T-cell leukemia virus by chromatin-insulator CTCF.
Cheng X; Joseph A; Castro V; Chen-Liaw A; Skidmore Z; Ueno T; Fujisawa JI; Rauch DA; Challen GA; Martinez MP; Green P; Griffith M; Payton JE; Edwards JR; Ratner L
PLoS Pathog; 2021 May; 17(5):e1009577. PubMed ID: 34019588
[TBL] [Abstract][Full Text] [Related]
7. Pentosan Polysulfate Demonstrates Anti-human T-Cell Leukemia Virus Type 1 Activities
Ma G; Yasunaga JI; Ohshima K; Matsumoto T; Matsuoka M
J Virol; 2019 Aug; 93(16):. PubMed ID: 31167921
[TBL] [Abstract][Full Text] [Related]
8. HTLV-1 Rex is required for viral spread and persistence in vivo but is dispensable for cellular immortalization in vitro.
Ye J; Silverman L; Lairmore MD; Green PL
Blood; 2003 Dec; 102(12):3963-9. PubMed ID: 12907436
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
Baratella M; Forlani G; Raval GU; Tedeschi A; Gout O; Gessain A; Tosi G; Accolla RS
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005285. PubMed ID: 28095504
[TBL] [Abstract][Full Text] [Related]
10. Novel Interactions between the Human T-Cell Leukemia Virus Type 1 Antisense Protein HBZ and the SWI/SNF Chromatin Remodeling Family: Implications for Viral Life Cycle.
Alasiri A; Abboud Guerr J; Hall WW; Sheehy N
J Virol; 2019 Aug; 93(16):. PubMed ID: 31142665
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1.
Arnold J; Yamamoto B; Li M; Phipps AJ; Younis I; Lairmore MD; Green PL
Blood; 2006 May; 107(10):3976-82. PubMed ID: 16424388
[TBL] [Abstract][Full Text] [Related]
12. HTLV-1-host interactions on the development of adult T cell leukemia/lymphoma: virus and host gene expressions.
Tarokhian H; Rahimi H; Mosavat A; Shirdel A; Rafatpanah H; Akbarin MM; Bari A; Ramezani S; Rezaee SA
BMC Cancer; 2018 Dec; 18(1):1287. PubMed ID: 30577817
[TBL] [Abstract][Full Text] [Related]
13. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
14. Kinetic analysis of human T-cell leukemia virus type 1 gene expression in cell culture and infected animals.
Li M; Kesic M; Yin H; Yu L; Green PL
J Virol; 2009 Apr; 83(8):3788-97. PubMed ID: 19193802
[TBL] [Abstract][Full Text] [Related]
15. Functional Comparison of HBZ and the Related APH-2 Protein Provides Insight into Human T-Cell Leukemia Virus Type 1 Pathogenesis.
Panfil AR; Dissinger NJ; Howard CM; Murphy BM; Landes K; Fernandez SA; Green PL
J Virol; 2016 Jan; 90(7):3760-72. PubMed ID: 26819304
[TBL] [Abstract][Full Text] [Related]
16. Comparative virology of HTLV-1 and HTLV-2.
Martinez MP; Al-Saleem J; Green PL
Retrovirology; 2019 Aug; 16(1):21. PubMed ID: 31391116
[TBL] [Abstract][Full Text] [Related]
17. Human T-cell leukemia virus type 2 antisense viral protein 2 is dispensable for in vitro immortalization but functions to repress early virus replication in vivo.
Yin H; Kannian P; Dissinger N; Haines R; Niewiesk S; Green PL
J Virol; 2012 Aug; 86(16):8412-21. PubMed ID: 22623800
[TBL] [Abstract][Full Text] [Related]
18. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.
Kannagi M; Hasegawa A; Nagano Y; Kimpara S; Suehiro Y
Retrovirology; 2019 Aug; 16(1):23. PubMed ID: 31438973
[TBL] [Abstract][Full Text] [Related]
19. Human T cell lymphotropic virus type I (HTLV-I) p12I is dispensable for HTLV-I transmission and maintenance of infection in vivo.
Furukawa Y; Usuku K; Izumo S; Osame M
AIDS Res Hum Retroviruses; 2004 Oct; 20(10):1092-9. PubMed ID: 15585100
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of ABL1 tyrosine kinase reduces HTLV-1 proviral loads in peripheral blood mononuclear cells from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
Kodama D; Tanaka M; Matsuzaki T; Izumo K; Nakano N; Matsuura E; Saito M; Nagai M; Horiuchi M; Utsunomiya A; Takashima H; Kubota R; Izumo S
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008361. PubMed ID: 32667912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
